TXMD Stock Price Increases Over 35% Pre-Market: Why It Happened

By Amit Chowdhry ● February 8, 2021
  • The stock price of TherapeuticsMD Inc (NASDAQ: TXMD) is trading at over 35% pre-market. This is why it happened.

The stock price of TherapeuticsMD Inc (NASDAQ: TXMD) is trading at over 35% pre-market. There is no direct news from the company, but there is an uptick in discussions about the company on social media plus Seeking Alpha published a bullish report about the company recently. 

“The possible vitaCare spin-off for example could provide TXMD with a vital source of cash ($50 million-plus in non-dilutive funds) plus also enable the company retain an interest in the newly formed entity. If this transaction can go through, it will obviously buy TXMD time especially if adverse trading conditions persist as a result of the ongoing pandemic,” says the Seeking Alpha report. 

The report also noted that sales increased by 80% sequentially in Q3 at $19.3 million, which was largely driven by the growth of the Annovera birth control product. The growth of Annovera sales is expected to continue this year. And multiple additional patents are expected to offer the company more protection against competition over time.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.